Splenic inflammatory pseudotumor mimicking primary splenic malignancy.

1. Michailov G, Laporte JPH, Lesage S, et al. Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis. Bone Marrow Transplant 1996; 17:569-72. 2. Martino R, Lopez R, Sureda A, Brunet S, Domingo Albos A. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Haematologica 1997; 82:297-304. 3. Bjerke JW, Meyers JD, Bowden RA. Hepatosplenic candidiasis – A contraindication to marrow transplantation? Blood 1994; 84:2811-4. 4. Micozzi A, Cartoni C, Monaco M, Martino P, Zittoun R, Mandelli F. High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission. Support Care Cancer 1996; 4:294-7. 5. Picardi M, Selleri C, Camera A, Catalano L, Rotoli B. Early detection by ultrasound scan of severe postchemotherapy gut complications in patients with acute leukemia. Haematologica 1999; 84:222-5. 6. Woolley I, Curtis D, Szer J, et al. High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia. Leuk Lymphoma 1997; 27:469-74. 7. Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30-year experience. Clin Infec Disease 1993; 17:484-90. 8. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 1992; 116:821-8.